Product NDC: | 55390-077 |
Proprietary Name: | Prochlorperazine Edisylate |
Non Proprietary Name: | Prochlorperazine Edisylate |
Active Ingredient(s): | 5 mg/mL & nbsp; Prochlorperazine Edisylate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-077 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040540 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040726 |
Package NDC: | 55390-077-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-077-01) > 10 mL in 1 VIAL |
NDC Code | 55390-077-01 |
Proprietary Name | Prochlorperazine Edisylate |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-077-01) > 10 mL in 1 VIAL |
Product NDC | 55390-077 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Prochlorperazine Edisylate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20040726 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | PROCHLORPERAZINE EDISYLATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |